Search alternatives:
point decrease » point increase (Expand Search)
non decrease » note decreased (Expand Search), fold decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
non decrease » note decreased (Expand Search), fold decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
41401
Image_1_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.JPEG
Published 2024“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
-
41402
Data_Sheet_12_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF
Published 2024“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
-
41403
Table_1_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.DOC
Published 2024“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
-
41404
Data_Sheet_3_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF
Published 2024“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
-
41405
Data_Sheet_15_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF
Published 2024“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
-
41406
Data_Sheet_5_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF
Published 2024“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
-
41407
Data_Sheet_1_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF
Published 2024“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
-
41408
Data_Sheet_4_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF
Published 2024“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
-
41409
Data_Sheet_7_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF
Published 2024“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
-
41410
Data_Sheet_8_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF
Published 2024“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
-
41411
Data_Sheet_11_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF
Published 2024“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
-
41412
Data_Sheet_9_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF
Published 2024“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
-
41413
Data_Sheet_6_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF
Published 2024“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
-
41414
Table_4_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.DOC
Published 2024“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
-
41415
Table_2_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.DOC
Published 2024“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
-
41416
Data_Sheet_13_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF
Published 2024“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
-
41417
Table_3_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.DOC
Published 2024“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
-
41418
Table 1_The kinetic behavior of matrine in pig intestinal lumen after oral administration and its physiologically based pharmacokinetic modeling.docx
Published 2025“…The concentration-time data were analysed by non-compartmental method. Subsequently, a four-compartment PBPK model was developed and validated.…”
-
41419
Image_4_Systemic Inflammation Increases the Susceptibility to Levodopa-Induced Dyskinesia in 6-OHDA Lesioned Rats by Targeting the NR2B-Medicated PKC/MEK/ERK Pathway.JPEG
Published 2021“…</p><p>Conclusion: This study suggests that systemic inflammation, by exacerbating preexisting neuroinflammation and facilitating NR2B subunit activity, may play a crucial role in the development of LID. The administration of Clo-lipo restores the effects of LPS and decreases the susceptibility to LID in 6-OHDA lesioned rats.…”
-
41420
Image_1_Systemic Inflammation Increases the Susceptibility to Levodopa-Induced Dyskinesia in 6-OHDA Lesioned Rats by Targeting the NR2B-Medicated PKC/MEK/ERK Pathway.JPEG
Published 2021“…</p><p>Conclusion: This study suggests that systemic inflammation, by exacerbating preexisting neuroinflammation and facilitating NR2B subunit activity, may play a crucial role in the development of LID. The administration of Clo-lipo restores the effects of LPS and decreases the susceptibility to LID in 6-OHDA lesioned rats.…”